Search for: "IN RE KUBIN"
Results 41 - 60
of 68
Sorted by Relevance
|
Sort by Date
9 Jan 2020, 4:50 pm
” In re Kubin, 561 F.3d 1351, 1357 (Fed. [read post]
18 Jul 2011, 8:21 am
Alphapharm, In re Kubin While theoretically, KSR lowered the bar to obviousness by allowing consideration of obvious to try, obviousness-based patent attacks have met with little success Claims and patents covering chemical compounds of a particular structure remain strong Consider a narrow claim to particular compounds of interest Evaluate your arsenal of secondary considerations to understand the strength/weakness of your claim Obviousness-Type Double Patenting – a later… [read post]
4 Feb 2008, 3:16 am
The CAFC upheld the Board under the 'broadest reasonable interpretation rule'"A link to precedential and informative decisions from the Board of Appeals: [www.uspto.gov] "This link provides three post KSR decisions on obviousness - Catan, Kubin, and Smith. [read post]
18 Jul 2011, 8:21 am
Alphapharm, In re Kubin While theoretically, KSR lowered the bar to obviousness by allowing consideration of obvious to try, obviousness-based patent attacks have met with little success Claims and patents covering chemical compounds of a particular structure remain strong Consider a narrow claim to particular compounds of interest Evaluate your arsenal of secondary considerations to understand the strength/weakness of your claim Obviousness-Type Double Patenting – a later… [read post]
12 Oct 2018, 1:24 pm
See In re Kubin, 561F.3d 1351, 1359 (Fed. [read post]
13 May 2009, 11:44 pm
" In re Kubin, __ F.3d __, No. 2008-1184, slip op. at 14 (Fed. [read post]
9 Oct 2014, 11:49 am
I anticipate that if there are any crew members from these countries, they will not be be re-hired when they return home on vacation. [read post]
9 Dec 2011, 2:44 am
(Re)formulation of the technical problem in the sense referred to here iscarried out essentially for the purpose of assessing whether or not theinvention is or is not obvious. [read post]
17 Feb 2011, 11:58 am
. -2010 – Examination Guidelines Update: Developments in the Obviousness Inquiry after KSR Analysis must be made explicit Applies to all arts equally (In re Kubin) Includes examples kof both obvious and nonobvious claims from Federal Circuit cases (combining prior art elements, substituting one known element for another, “obvious to try”, consideration of evidence. [read post]
27 Sep 2008, 12:08 am
You can separately subscribe to the Pharma & Biotech edition of the Global week in Review by subscribing by email, or selecting ‘all posts’ or Pharma, Biotech & Chem' for the RSS option at the Subscribe page: [duncanbucknell.com] Highlights this week included: Canada/Africa: Apotex ships patented AIDS drugs to Rwanda under Canada's Access to Medicines Regime (CAMR) (Managing Intellectual Property) (GenericsWeb) Consolidation in the generic… [read post]
17 Jul 2017, 9:41 am
Cir. 2012), and Inre Kubin, 561 F.3d 1351, 1357 (Fed. [read post]
12 Mar 2016, 7:44 am
They’re uniquely positioned to provide standardization guidance, especially since they’re dealing with patents that will be very valuable if the standard is accepted. [read post]
7 Oct 2013, 11:06 am
An analysis of obviousness must be based on several factual inquiries: (1) the scope and content of the prior art; (2) the differ- ences between the prior art and the claims at is- sue; (3) the level of ordinary skill in the art at the time the invention was made; and (4) objective ev- idence of nonobviousness, if any.In re Kubin, 561 F.3d 1351, 1355 (Fed. [read post]
15 Feb 2010, 9:15 am
" See In re Gal, 980 F.2d 717, 25 USPQ2d 1076 (Fed. [read post]
2 Sep 2010, 10:51 am
The Obvious To Try Rationale In re Kubin, 561 F.3d 1351 (Fed. [read post]
24 Sep 2010, 1:15 pm
In re Kubin, 561 F.3d 1351 (Fed. [read post]
6 Aug 2009, 3:25 pm
Related posts:Unpredictable Nature of Chemicals Can Defeat Obviousness Claim After a final judgment upholding the validity of the Procter...Mere Mention of a Drug Not Enough to Disclose Treatment After the district court held that an earlier patent (Pat....Court: It’s Not An Invention If You Use Conventional Techniques To Make It In In re Kubin (08-1184), the US Court of Appeals... [read post]
17 Feb 2011, 9:07 pm
In re Kubin, a biotech case, described this as "throw[ing] metaphorical darts at a board filled with combinatorial prior art possibilities," and said that obvious-to-try is not appropriate for such cases. [read post]
9 Jan 2009, 3:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Humira (Adalimumab) – US: Bayer HealthCare files patent infringement suit against Abbott Laboratories over Humira; Abbott fires back with lawsuit claiming Bayer’s patent invalid, not infringed or unenforceable (Law360) (Law360) (Philip Brooks' Patent Infringement Updates) (Patent Baristas) Sprycel (Dasatinib)… [read post]
31 Jul 2023, 1:47 pm
Cir. 2020) (quoting In re Kubin, 561 F.3d 1351, 1357 (Fed. [read post]
